Eli Lilly | LLY - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
AbbVie 23.96 0.93 2026-06
Abbott 34.85 10.99 2026-09
ALKERMES 135.81 96.48 2026-06
Amgen 18.07 1.77 2026-06
AstraZeneca 25.34 4.25 2026-06
Baxter International 20.35 131.6 2026-09
Biogen 29.15 5.92 2026-09
Bristol-Myers Squibb 10.44 5.7 2026-09
Drreddys Laboratories 19.25 0.98 2026-03
Eli Lilly 64.5 31.61 2026-09
Gilead Sciences 17.68 4.18 2026-09
GlaxoSmithKline 9.72 0.9 2026-09
Glaxosmithkline 15.09 3.43 2026-03
J&J 25.86 3.57 2026-09
Medtronic 18.15 1.51 2026-06
Merck 34.36 2.11 2026-09
Neurocrine Biosciences 22.1 5.99 2026-06
Novartis 22.41 2.24 2026-06
Novartis 21.36 3.57 2026-03
Novo Nordisk 10.17 2.61 2026-06
Perrigo 27.45 31.51 2026-03
Pfizer 11.48 2.16 2026-06
Phibro Animal Health 13.82 4.04 2025-12
Prestige Brands 11.89 3.75 2026-06
Regeneron Pharmaceuticals 15.46 9.68 2026-06
Roche Holding 16.48 0.39 2026-06
Sanofi 18.96 7.12 2026-06
Sanofi 20.87 5.12 2026-03
United Therapeutics 19.15 1.27 2026-06
Zoetis 10.58 8.22 2026-06